Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Daniel J. Oh, Judy L. Chen, Thasarat S. Vajaranant & Mark S. Dikopf. (2019) Brimonidine tartrate for the treatment of glaucoma. Expert Opinion on Pharmacotherapy 20:1, pages 115-122.
Read now
Read now
Toyoaki Tsumura, Keiji Yoshikawa, Tairo Kimura, Hirotaka Suzumura, Miwako Kawashima, Mami Nanno, Kiyotaka Ishijima & Ryuji Takeda. (2014) The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients. Clinical Ophthalmology 8, pages 1681-1687.
Read now
Read now
Sky K Chew, Simon E Skalicky & Ivan Goldberg. (2014) Brinzolamide plus brimonidine for the treatment of glaucoma: an update. Expert Opinion on Pharmacotherapy 15:16, pages 2461-2471.
Read now
Read now
Jin-Wei Cheng, Shi-Wei Cheng, Dan-Yang Yu, Rui-Li Wei & Guo-Cai Lu. (2012) Meta-analysis of α2-adrenergic agonists versus carbonic anhydrase inhibitors as adjunctive therapy. Current Medical Research and Opinion 28:4, pages 543-550.
Read now
Read now
Robert D Fechtner, Paul Harasymowycz, Donald R Nixon, Steven D Vold, Fiaz Zaman, Julia M Williams & David A Hollander. (2011) Twelve-week, randomized, multicenter study comparing a fixed combination of brimonidine-timolol with timolol as therapy adjunctive to latanoprost. Clinical Ophthalmology 5, pages 945-953.
Read now
Read now
James F.T. Li Yim & Donald M. Montgomery. (2011) The intraocular pressure reducing effect of brinzolamide as adjunctive therapy to latanoprost. Current Medical Research and Opinion 27:8, pages 1499-1502.
Read now
Read now
Konstantin Gugleta. (2010) Topical carbonic anhydrase inhibitors and visual function in glaucoma and ocular hypertension. Current Medical Research and Opinion 26:6, pages 1255-1267.
Read now
Read now
Makoto Ishikawa & Takeshi Yoshitomi. (2009) Effects of brinzolamide vs timolol as an adjunctive medication to latanoprost on circadian intraocular pressure control in primary open-angle glaucoma Japanese patients. Clinical Ophthalmology 3, pages 493-500.
Read now
Read now
Articles from other publishers (11)
Jin A Kim & Heeyoung Lee. (2021) Effectiveness and Safety Verification of Brinzolamide Combination Therapy on Primary Open-angle Glaucoma or Ocular Hypertension: A Systematic Review and Meta-analysis Study. Korean Journal of Clinical Pharmacy 31:3, pages 205-215.
Crossref
Crossref
Yuanzhi Liu, Junyi Zhao, Xiaoyan Zhong, Qiming Wei & Yilan Huang. (2019) Efficacy and Safety of Brinzolamide as Add-On to Prostaglandin Analogues or β-Blocker for Glaucoma and Ocular Hypertension: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology 10.
Crossref
Crossref
Kenji Inoue, Mieko Masumoto, Kyoko Ishida & Goji Tomita. (2017) Efficacy and Safety of Switching from Prostaglandin Analog Therapy to Prostaglandin / Timolol Fixed Combination or Prostaglandin / Brimonidine Therapy. The Open Ophthalmology Journal 11:1, pages 156-163.
Crossref
Crossref
Mitsuhiro Imasawa, Joji Tanabe, Fumiko Kashiwagi & Kenji Kashiwagi. (2016) Efficacy and Safety of Switching Latanoprost Monotherapy to Bimatoprost Monotherapy or Combination of Brinzolamide and Latanoprost. The Open Ophthalmology Journal 10:1, pages 94-102.
Crossref
Crossref
Paul Harasymowycz, Catherine Birt, Patrick Gooi, Lisa Heckler, Cindy Hutnik, Delan Jinapriya, Lesya Shuba, David Yan & Radmila Day. (2016) Medical Management of Glaucoma in the 21st Century from a Canadian Perspective. Journal of Ophthalmology 2016, pages 1-22.
Crossref
Crossref
Quang H. NguyenMatthew G. McMenemyTony RealiniJess T. WhitsonStephen M. Goode. (2013) Phase 3 Randomized 3-Month Trial with an Ongoing 3-Month Safety Extension of Fixed-Combination Brinzolamide 1%/Brimonidine 0.2%. Journal of Ocular Pharmacology and Therapeutics 29:3, pages 290-297.
Crossref
Crossref
Florent Aptel, Christophe Chiquet & Jean-Paul Romanet. (2012) Intraocular Pressure-Lowering Combination Therapies with Prostaglandin Analogues. Drugs 72:10, pages 1355-1371.
Crossref
Crossref
Stella Arthur & Louis B. Cantor. (2011) Update on the role of alpha-agonists in glaucoma management. Experimental Eye Research 93:3, pages 271-283.
Crossref
Crossref
John H.K. Liu, Felipe A. Medeiros, J. Rigby Slight & Robert N. Weinreb. (2010) Diurnal and Nocturnal Effects of Brimonidine Monotherapy on Intraocular Pressure. Ophthalmology 117:11, pages 2075-2079.
Crossref
Crossref
Thomas E. Bournias & Jerry Lai. (2009) Brimonidine Tartrate 0.15%, Dorzolamide Hydrochloride 2%, and Brinzolamide 1% Compared as Adjunctive Therapy to Prostaglandin Analogs. Ophthalmology 116:9, pages 1719-1724.
Crossref
Crossref
Robert L Stamper, Marc F Lieberman & Michael V Drake. 2009. Becker-Shaffer's Diagnosis and Therapy of the Glaucomas. Becker-Shaffer's Diagnosis and Therapy of the Glaucomas
376
391
.